| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 14:22:47 UTC |
|---|
| Update Date | 2021-09-26 23:09:19 UTC |
|---|
| HMDB ID | HMDB0254899 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Mosapride |
|---|
| Description | Mosapride, also known as mosart, belongs to the class of organic compounds known as aminophenyl ethers. These are aromatic compounds that contain a phenol ether, which carries an amine group on the benzene ring. Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist. Mosapride is a very strong basic compound (based on its pKa). The neurogenesis is due to mosapride's effect on the 5-HT4 receptor where it acts as an agonist. It is recommended to be taken on an empty stomach (i.e. at least one hour before food or two hours after food). Mosapride also promotes neurogenesis in the gastrointestinal tract which may prove useful in certain bowel disorders. Unlike some other prokinetic agents, mosapride has little effect on potassium channels, no effect on hERG transfected cells, and no effect on cardiovascular function that could be detected in tests on humans. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist, which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans, and is used for the treatment of gastritis, gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome. In addition to its prokinetic properties, mosapride also exerts anti-inflammatory effects on the gastrointestinal tract which may contribute to some of its therapeutic effects. Due to the pharmacokinetics of mosapride, it would take 1,000–3,000 times the therapeutic dose to elicit cardiovascular effects. This compound has been identified in human blood as reported by (PMID: 31557052 ). Mosapride is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mosapride is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 InChI=1S/C21H25ClFN3O3/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27) |
|---|
| Synonyms | | Value | Source |
|---|
| Mosart | Kegg | | 4-amino-5-chloro-2-Ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide | MeSH | | Mosapride citrate | MeSH | | Mosapride ui05MSP015CT | MeSH |
|
|---|
| Chemical Formula | C21H25ClFN3O3 |
|---|
| Average Molecular Weight | 421.9 |
|---|
| Monoisotopic Molecular Weight | 421.1568475 |
|---|
| IUPAC Name | 4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide |
|---|
| Traditional Name | mosapride |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 |
|---|
| InChI Identifier | InChI=1S/C21H25ClFN3O3/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27) |
|---|
| InChI Key | YPELFRMCRYSPKZ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminophenyl ethers. These are aromatic compounds that contain a phenol ether, which carries an amine group on the benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenol ethers |
|---|
| Sub Class | Aminophenyl ethers |
|---|
| Direct Parent | Aminophenyl ethers |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminophenyl ether
- Phenoxy compound
- Phenylmethylamine
- Benzylamine
- Aniline or substituted anilines
- Alkyl aryl ether
- Halobenzene
- Fluorobenzene
- Chlorobenzene
- Aralkylamine
- Oxazinane
- Aryl chloride
- Monocyclic benzene moiety
- Aryl halide
- Aryl fluoride
- Morpholine
- Tertiary aliphatic amine
- Tertiary amine
- Oxacycle
- Azacycle
- Carboximidic acid
- Carboximidic acid derivative
- Organoheterocyclic compound
- Dialkyl ether
- Ether
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Primary amine
- Organohalogen compound
- Organochloride
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.8626 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.75 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1325.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 190.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 167.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 173.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 85.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 343.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 405.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 368.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 824.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 335.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1065.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 274.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 309.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 295.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 282.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 19.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Mosapride,1TMS,isomer #1 | CCOC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3538.2 | Semi standard non polar | 33892256 | | Mosapride,1TMS,isomer #1 | CCOC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3050.7 | Standard non polar | 33892256 | | Mosapride,1TMS,isomer #1 | CCOC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 4173.9 | Standard polar | 33892256 | | Mosapride,1TMS,isomer #2 | CCOC1=CC(N)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 3395.1 | Semi standard non polar | 33892256 | | Mosapride,1TMS,isomer #2 | CCOC1=CC(N)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 2993.5 | Standard non polar | 33892256 | | Mosapride,1TMS,isomer #2 | CCOC1=CC(N)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 4404.7 | Standard polar | 33892256 | | Mosapride,2TMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3416.4 | Semi standard non polar | 33892256 | | Mosapride,2TMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3081.5 | Standard non polar | 33892256 | | Mosapride,2TMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3964.8 | Standard polar | 33892256 | | Mosapride,2TMS,isomer #2 | CCOC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 3494.7 | Semi standard non polar | 33892256 | | Mosapride,2TMS,isomer #2 | CCOC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 2988.3 | Standard non polar | 33892256 | | Mosapride,2TMS,isomer #2 | CCOC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 3935.8 | Standard polar | 33892256 | | Mosapride,3TMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 3384.3 | Semi standard non polar | 33892256 | | Mosapride,3TMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 2931.0 | Standard non polar | 33892256 | | Mosapride,3TMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C | 3691.0 | Standard polar | 33892256 | | Mosapride,1TBDMS,isomer #1 | CCOC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3729.8 | Semi standard non polar | 33892256 | | Mosapride,1TBDMS,isomer #1 | CCOC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3254.4 | Standard non polar | 33892256 | | Mosapride,1TBDMS,isomer #1 | CCOC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 4237.9 | Standard polar | 33892256 | | Mosapride,1TBDMS,isomer #2 | CCOC1=CC(N)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 3589.2 | Semi standard non polar | 33892256 | | Mosapride,1TBDMS,isomer #2 | CCOC1=CC(N)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 3184.8 | Standard non polar | 33892256 | | Mosapride,1TBDMS,isomer #2 | CCOC1=CC(N)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 4436.3 | Standard polar | 33892256 | | Mosapride,2TBDMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3806.2 | Semi standard non polar | 33892256 | | Mosapride,2TBDMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 3449.0 | Standard non polar | 33892256 | | Mosapride,2TBDMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1 | 4039.0 | Standard polar | 33892256 | | Mosapride,2TBDMS,isomer #2 | CCOC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 3830.9 | Semi standard non polar | 33892256 | | Mosapride,2TBDMS,isomer #2 | CCOC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 3348.3 | Standard non polar | 33892256 | | Mosapride,2TBDMS,isomer #2 | CCOC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 4065.6 | Standard polar | 33892256 | | Mosapride,3TBDMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 3908.5 | Semi standard non polar | 33892256 | | Mosapride,3TBDMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 3508.3 | Standard non polar | 33892256 | | Mosapride,3TBDMS,isomer #1 | CCOC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N(CC1CN(CC2=CC=C(F)C=C2)CCO1)[Si](C)(C)C(C)(C)C | 3855.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Mosapride GC-MS (Non-derivatized) - 70eV, Positive | splash10-0597-0912000000-b7fb0a6bfad44e4d20a9 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Mosapride GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Mosapride , positive-QTOF | splash10-00dj-0910400000-7b60d0e3ee1a9a5d92c9 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mosapride 35V, Positive-QTOF | splash10-0002-0900100000-d72adcdbd3fb3b699ec3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 10V, Positive-QTOF | splash10-00di-0141900000-89277eb9b50d85f049be | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 20V, Positive-QTOF | splash10-00di-0591200000-f1cf3e8e66eaa1853013 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 40V, Positive-QTOF | splash10-0fk9-0920000000-cd3d58dda6a46ffac69f | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 10V, Negative-QTOF | splash10-00di-0021900000-dd479d6e085a505fe51c | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 20V, Negative-QTOF | splash10-022d-3797600000-1fb32b561ba50adbc102 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 40V, Negative-QTOF | splash10-0006-6952000000-cfe15cc335de41b652bd | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 10V, Negative-QTOF | splash10-00di-0103900000-f610cd2b5ce8838638be | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 20V, Negative-QTOF | splash10-0006-0429200000-d9e7c9c901c637622eb5 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapride 40V, Negative-QTOF | splash10-001j-1791000000-c48fe484ae22a51681b1 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|